GlassScriptPhysician profile
Kenneth Vera
NPI 1417454182
$5,456.01
in general payments reported to CMS, 2019-2025
15 companies · $1,435 in 2025
The $1,435 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $935 · 2023: $2,017 · 2024: $1,068 · 2025: $1,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,520.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,492.34 | 2022-2025 | Biktarvy, Descovy |
| Novo Nordisk INC | $1,217.58 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $663.27 | 2022-2025 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $623.86 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Viiv Healthcare Company | $384.98 | 2023-2024 | Dovato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $311.14 | 2023-2024 | Xifaxan, Trulance |
| Kowa Pharmaceuticals America, INC. | $183.67 | 2025 | Zoryve |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $150.00 | 2025 | |
| Abbvie INC. | $135.23 | 2024 | |
| Medtronic, INC. | $103.02 | 2022 | |
| Ethicon US, LLC | $103.02 | 2022 | |
| Mannkind Corporation | $34.15 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $23.44 | 2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $15.66 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $14.65 | 2023 | Pifeltro, Delstrigo, Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Vera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.